Provide Feedback |

Press Release/Announcement

Relenza (zanamivir) inhalation powder.

March 12, 2010

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; October 9, 2009.

This alert notifies health care providers of the potential for patient harm if a particular inhalation powder is reconstituted and incorrectly administered.

Information

Related Resources From the Same Author(s)

Potentially fatal errors with GDH-PQQ [glucose dehydrogenase pyrroloquinoline quinone] glucose monitoring technology.

March 12, 2010

Tamiflu (oseltamivir) for oral suspension: potential medication errors.

November 3, 2009

FDA advises health care professionals and patients about insulin pen packaging and dispensing.

October 28, 2020

Potential for medication overdose with ENFit low dose tip syringe: FDA Safety Communication.

October 20, 2021

Serious adverse events from accidental ingestion by children of over-the-counter eye drops and nasal sprays.

November 7, 2012

Wear face masks with no metal during MRI exams.

December 16, 2020

FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration.

April 8, 2020

Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).

June 22, 2011

Hospira issues a voluntary nationwide recall for one lot of 0.5% Bupivacaine Hydrochloride Injection, USP and one lot of 1% Lidocaine HCl Injection, USP due to mislabeling.

May 19, 2021

FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder.

August 5, 2020

Related Resources

FDA Safety Communication: update--robotically-assisted surgical devices in mastectomy.

August 20, 2021

Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.

October 10, 2018

Fentanyl transdermal system (marketed as Duragesic) information.

July 10, 2015

Information for healthcare professionals: risk of transmission of blood-borne pathogens from shared use of insulin pens.

March 4, 2015

Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).

June 22, 2011

New dosing recommendations to prevent potential Valcyte (valganciclovir) overdose in pediatric transplant patients.

September 29, 2010

Serious medication errors from intravenous administration of nimodipine oral capsules.

August 11, 2010

Nimodipine Capsules (marketed as Nimotop).

July 15, 2010

Heparin sodium injection 10,000 units/mL, and HEP-LOCK U/P 10 units/mL medication errors.

March 22, 2010

Maalox Total Relief and Maalox Liquid Products: Medication Use Errors.

March 3, 2010

See More About The Topic

Health Care Providers

Risk Managers

Quality and Safety Professionals

Infectious Diseases

Administration Errors

To sign up for updates or to access your subscriber preferences, please enter your email address below.

5600 Fishers Lane
Rockville, MD 20857
Telephone: (301) 427-1364

Relenza (zanamivir) inhalation powder.

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

Relenza (zanamivir) inhalation powder.

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

Submit Your Innovations

Continue as a Guest

Continue Logged In

Submit Your Innovations

Continue as a Guest

Continue logged in

New Users to the PSNet site

Submit Your Training

Continue as a Guest

Continue Logged In

Submit Your Training

Continue as a Guest

Continue Logged In

New Users to the PSNet site

Submit Your Toolkit

Continue as a Guest

Continue Logged In

Submit Your Toolkit

Continue as a Guest

Continue Logged In

New Users to the PSNet site

Submit Your WebM&M Case

Continue as a Guest

Continue Logged In

Submit Your WebM&M Case

Continue as a Guest

Already have a PSNet

Account?

New Users